Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Oncology Today with Dr Neil Love
00:00
DB09 Results and First-Line HER2 Strategy
Hope and Sara review DB09, first-line trastuzumab deruxtecan decisions, and maintenance strategy considerations.
Play episode from 08:03
Transcript
